Anika Therapeutics (ANIK) Intangibles (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Intangibles data on file, last reported at $1.7 million in Q1 2026.

• Intangibles for Q1 2026 came in at $1.7 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed 0.0% YoY), and the FY2025 annual result was $1.6 million, down 91.68% from the prior year.
• Intangibles climbed to $1.7 million in Q1 2026 per ANIK's latest filing, from $1.6 million in the prior quarter.
• Over five years, Intangibles peaked at $112.1 million in Q4 2022 and troughed at $600000.0 in Q3 2024.
• A 5-year average of $44.0 million and a median of $49.9 million in 2024 frame the typical range for Intangibles.
• On a YoY basis, Intangibles climbed as much as 670.03% in 2024 and fell as far as 99.46% in 2024.
• A 5-year view of Intangibles shows it stood at $112.1 million in 2022, then tumbled by 97.7% to $2.6 million in 2023, then soared by 670.03% to $19.8 million in 2024, then sank by 91.68% to $1.6 million in 2025, then rose by 3.03% to $1.7 million in 2026.
• Business Quant data shows ANIK's Intangibles at $1.7 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.